[Federal Register Volume 65, Number 33 (Thursday, February 17, 2000)]
[Notices]
[Page 8181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-3804]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Orthopaedic and Rehabilitation Devices Panel of the Medical 
Devices Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.

    Name of Committee: Orthopaedic and Rehabilitation Devices Panel 
of the Medical Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on February 18, 2000, 9 
a.m. to 5 p.m.
    Location: 9200 Corporate Blvd., Corporate Bldg., conference room 
20B, Rockville, MD.
    Contact Person: Hany W. Demian, Center for Devices and 
Radiological Health (HFZ-410), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-594-2036, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12521. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: FDA staff will present an update to the committee 
regarding the status of submissions from past panel meetings.
    Procedure: On February 18, 2000, from 9 a.m. to 10 a.m., the 
meeting is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues appropriate 
for the committee. Written submissions may be made to the contact 
person by February 14, 2000. Those desiring to make formal oral 
presentations should notify the contact person before February 14, 
2000, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses 
of proposed participants, and an indication of the approximate time 
requested to make their presentation. Time allotted for the 
presentations may be limited.
    Closed Committee Deliberations: On February 18, 2000, from 10 
a.m. to 5 p.m., the meeting will be closed to the public. The 
committee will hear and review trade secret and/or confidential 
commercial information on a product development protocol. This 
portion of the meeting is closed to permit discussion of this 
information (5 U.S.C. 552b(c)(4)).
    FDA regrets that it was unable to publish this notice 15 days 
prior to the February 18, 2000, Orthopaedic and Rehabilitation 
Devices Panel of the Medical Devices Advisory Committee meeting. 
Because the agency believes there is some urgency to bring these 
issues to public discussion and qualified members of the Orthopaedic 
and Rehabilitation Devices Panel of the Medical Devices Advisory 
Committee were available at this time, the Commissioner of Food and 
Drugs concluded that it was in the public interest to hold this 
meeting even if there was not sufficient time for the customary 15-
day public notice.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 10, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-3804 Filed 2-16-00; 8:45 am]
BILLING CODE 4160-01-F